View all cases
UPC APP 8391/2024
EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers
- Case details
- Status—Action—CategoryOther procedural
- Parties
- Claimants
- Roche Diabetes Care GmbHOperating co.
Representatives- Christof Augenstein-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Robert Knaps-Kather Augenstein
- Thomas Kronbergersupporting-Grünecker Patent- und Rechtsanwälte PartGmbH
Respondents- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
Representatives- Charlotte Garnitsch-Taylor Wessing
- Wim Maas-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
- Division
- —
- Judges
- Technology
- InstrumentsMedical technology
- Language
- —
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Paolo Catallozzi | Locked |
At the UPC: Roche Group (29 cases)·Tandem Diabetes Care Group (18 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
UPC CoA 120/2025·UPC CFI 11/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023 and 4 more
1 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: 2024
Decisions
- 2024-02-20
Summary: The Central Division Paris seat granted Roche Diabetes Care GmbH's request for an extension of the time period for filing the defence to revocation in the pending revocation action concerning EP 2 196 231, pending a decision on the preliminary objection to jurisdiction.
Show the legal issues (3)
- Extension of time period for defence to revocation
- Preliminary objection to jurisdiction
- Procedural order
Documents
- 12DF8D94F487E3E0D0D3523EDD6468DD_en.pdf2024-02-20EN